GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » EV-to-EBITDA

Fractyl Health (Fractyl Health) EV-to-EBITDA : -13.13 (As of May. 11, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fractyl Health's enterprise value is $350.99 Mil. Fractyl Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-26.73 Mil. Therefore, Fractyl Health's EV-to-EBITDA for today is -13.13.

The historical rank and industry rank for Fractyl Health's EV-to-EBITDA or its related term are showing as below:

GUTS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -17.47   Med: -10.65   Max: -9.18
Current: -13.13

During the past 5 years, the highest EV-to-EBITDA of Fractyl Health was -9.18. The lowest was -17.47. And the median was -10.65.

GUTS's EV-to-EBITDA is ranked worse than
100% of 460 companies
in the Biotechnology industry
Industry Median: 9.53 vs GUTS: -13.13

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Fractyl Health's stock price is $6.19. Fractyl Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.916. Therefore, Fractyl Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Fractyl Health EV-to-EBITDA Historical Data

The historical data trend for Fractyl Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health EV-to-EBITDA Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - - - -

Fractyl Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Fractyl Health's EV-to-EBITDA

For the Biotechnology subindustry, Fractyl Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fractyl Health's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Fractyl Health's EV-to-EBITDA falls into.



Fractyl Health EV-to-EBITDA Calculation

Fractyl Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=350.985/-26.732
=-13.13

Fractyl Health's current Enterprise Value is $350.99 Mil.
Fractyl Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fractyl Health  (NAS:GUTS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Fractyl Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.19/-0.916
=At Loss

Fractyl Health's share price for today is $6.19.
Fractyl Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.916.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Fractyl Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Fractyl Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Fractyl Health (Fractyl Health) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hartwell Avenue, Lexington, MA, USA, 02421
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.